Skip to main content
. 2017 Jan 29;8(9):14462–14478. doi: 10.18632/oncotarget.14895

Figure 4. Genetic interaction between RPL5 alterations and TP53 or c-MYC alterations.

Figure 4

(A) Co-occurrence of RPL5 and TP53 alterations in GBM, SKCM and BRCA. (B) Co-occurrence of RPL5 and c-MYC alterations in GBM, SKCM and BRCA.